📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
14
MNKD Latest News & AI Sentiment Analysis
1 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 3 ARTICLES
MannKind: New Approvals Majorly Increase MannKind's Prospects (NASDAQ:MNKD)
MannKind (MNKD) has achieved regulatory approvals that expand its commercial opportunity across multiple therapeutic areas. The...
MannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload Transcript
MannKind Corporation (MNKD) has secured FDA approval for Furoscix ReadyFlow, a significant milestone for the biopharmaceutical company's...
MannKind Announces $50 Million Private Placement
MannKind Corporation (MNKD) announced a $50 million private placement to institutional investors, with closing expected on or around...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice